Siga Technologies (SIGA) Long-Term Deferred Tax (2011 - 2025)
Siga Technologies' (SIGA) quarterly Long-Term Deferred Tax came in at $4.4 million in Q4 2025, down 59.2% YoY from $10.9 million in Q4 2024, and up 183.8% on a QoQ basis from $1.6 million in Q3 2025.
Siga Technologies (SIGA) Long-Term Deferred Tax (2011 - 2025) Analysis & Trends
Siga Technologies (SIGA) has 15 years of Long-Term Deferred Tax data on file, last reported at $4.4 million in Q4 2025.
- Quarterly Long-Term Deferred Tax fell 59.2% year-over-year to $4.4 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $4.4 million (down 59.2% YoY) and the FY2025 annual result came in at $4.4 million, down 59.2% from the prior year.
- Long-Term Deferred Tax rose to $4.4 million in Q4 2025, from $1.6 million in the prior quarter.
- In the past five years, Long-Term Deferred Tax ranged from a high of $12.1 million in Q3 2024 to a low of $1.6 million in Q3 2025.
- A 5-year average of $6.4 million and a median of $5.3 million in 2022 frame the typical range for Long-Term Deferred Tax.
- Annual changes were most pronounced in 2022 — Long-Term Deferred Tax soared 158.0% — and 2025, when it tumbled 87.11%.
- Tracing SIGA's Long-Term Deferred Tax over 5 years: stood at $2.4 million in 2021, then soared by 158.0% to $6.3 million in 2022, then surged by 76.76% to $11.0 million in 2023, then retreated by 1.75% to $10.9 million in 2024, then plunged by 59.2% to $4.4 million in 2025.
- The last three Long-Term Deferred Tax figures came in at $4.4 million (Q4 2025), $1.6 million (Q3 2025), and $4.0 million (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.94 Bn | 42.97 Bn | - |
| 2 | Teva Pharmaceutical Industries | 42.95 Bn | 39.30 Bn | 2.15 Bn |
| 3 | Zoetis | 31.58 Bn | 29.90 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.16 Bn | 19.49 Bn | 683.80 Mn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.53 Bn | 15.14 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.95 Bn | - |
| 10 | Siga Technologies | 213.74 Mn | 58.77 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 4.43 Mn |
| Sep 30, 2025 | 1.56 Mn |
| Jun 30, 2025 | 3.97 Mn |
| Mar 31, 2025 | 11.13 Mn |
| Dec 31, 2024 | 10.85 Mn |
| Sep 30, 2024 | 12.10 Mn |
| Jun 30, 2024 | 11.61 Mn |
| Mar 31, 2024 | 11.01 Mn |
| Dec 31, 2023 | 11.05 Mn |
| Sep 30, 2023 | 7.90 Mn |
| Jun 30, 2023 | 7.59 Mn |
| Mar 31, 2023 | 6.73 Mn |
| Dec 31, 2022 | 6.25 Mn |
| Sep 30, 2022 | 4.18 Mn |
| Jun 30, 2022 | 3.04 Mn |
| Mar 31, 2022 | 4.04 Mn |
| Dec 31, 2021 | 2.42 Mn |
| Sep 30, 2021 | 2.95 Mn |
| Jun 30, 2021 | 2.73 Mn |
| Mar 31, 2021 | 2.57 Mn |